Price$1.61+1.00 (+161.79%)
2025-08-262025-11-26
Latest news
25 items- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- PRMBody AI and Check-Cap Enter into Definitive Merger AgreementMerger to Create Combined Company Focused on Embodied AI for the Autonomous Workforce ISFIYA, ISRAEL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- MBody AI ("MBody AI") and Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ:CHEK) today announced that they have entered into a definitive Agreement and Plan of Merger (the "Merger"). If the Merger is approved by Check-Cap shareholders, it will create a combined company focused on embodied AI for the autonomous workforce. Check-Cap's legacy business will continue its research and development activities as part of the combined company. MBody AI is a market-leading artificial intelligence ("AI") company redefining the future of work through embodied
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 20-F filed by Check-Cap Ltd.20-F - Check-Cap Ltd (0001610590) (Filer)
- PRCheck-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During WartimeCheck-Cap Ltd. Issues Strong Condemnation of MediPharm Labs Chairman Chris Taves for Fabricated Defamatory Statements Press Releases Taves Times his Attack to Commence 23 Minutes before the Start of Shabbat to Delay the Company from Responding ISFIYA, ISRAEL, June 04, 2025 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:CHEK) ("Check-Cap" or the "Company"), a clinical-stage medical diagnostics company incorporated in Israel, today publicly condemned MediPharm Labs Corp. (LABS) ("MediPharm Labs") and its Chairman, Chris Taves, Head of Asia for BMO Capital Markets, for disseminating derogatory, false, and misleading statements about Check-Cap during a profoundly sensitive and challenging time
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- PRApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with ShareholdersCompany Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion Conference Call is a Blatant, Self-Serving Reaction by a Management Team Running Scared Following Apollo Capital's Intention to Nominate Six Highly Qualified Directors to MediPharm's Board Shareholders Deserve Answers From Management About Massive Underperformance, Failed Operational Strategies, Poor Capital Allocation, Outrageous Compensation, and Lack of Transparency Apollo Capital's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Ex
- PRMediPharm Labs Files Proxy Materials, Issues Chair's Letter to ShareholdersTORONTO, May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX:LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Special Meeting of Shareholders, scheduled for June 16, 2025. The Meeting Materials will be sent to shareholders in the coming days, and are available on the SEDAR+ website at www.sedarplus.ca. MediPharm's Board of Directors (the "Board") recommends that shareholders vote through the GREEN proxy or GREEN voting instruction card in support of the Company's nominees for Board of Dir
- PRApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value DestructionBelieves Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Trusted to Create Shareholder Value or Oversee Management! Company Leadership Lacks Any Credible Strategic Plan and Has Made Numerous Reckless Acquisitions While Rewarding Themselves with Excessive Compensation for Repeated Failures Apollo's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Execute Plan to Restore Value for ALL MediPharm Shareholders Urges MediPharm Shareholders to Vote for Wholesale Change at Annual Meeting Sends Le
- PRApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value DestructionBelieves Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Trusted to Create Shareholder Value or Oversee Management! Company Leadership Lacks Any Credible Strategic Plan and Has Made Numerous Reckless Acquisitions While Rewarding Themselves with Excessive Compensation for Repeated Failures Apollo's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Execute Plan to Restore Value for ALL MediPharm Shareholders Urges MediPharm Shareholders to Vote for Wholesale Change at Annual Meeting Sends Let
- SECSEC Form NT 20-F filed by Check-Cap Ltd.NT 20-F - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 6-K filed by Check-Cap Ltd.6-K - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form 20-F filed by Check-Cap Ltd.20-F - Check-Cap Ltd (0001610590) (Filer)
- SECSEC Form NT 20-F filed by Check-Cap Ltd.NT 20-F - Check-Cap Ltd (0001610590) (Filer)
CHEK FAQ
7 questionsWhat does Check-Cap Ltd. do?
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data...Where does CHEK stock trade?
Check-Cap Ltd. (CHEK) is listed on NASDAQ.What sector and industry is CHEK in?
Check-Cap Ltd. operates in the Health Care sector, Medical Electronics industry.When did Check-Cap Ltd. go public?
Check-Cap Ltd. (CHEK) completed its IPO in 2015.What are analysts saying about CHEK?
Check-Cap Ltd. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $300.00 price target on 2021-08-09. Recent price targets cluster around $300.00.What companies are similar to CHEK?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), NNOX (NANO-X IMAGING LTD). Compare CHEK side-by-side with any of them on Quantisnow.How can I track CHEK on Quantisnow?
Quantisnow aggregates Check-Cap Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CHEK to receive live email and push alerts on every new disclosure.